CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Clinical Trials
Original article

SetPoint® System Used for First Time in Pacific Northwest to Treat Patients with Rheumatoid Arthritis in Clinical Practice

SetPoint® SystemPositive
AI Analysis

Summary

SetPoint Medical's FDA-approved SetPoint® System for rheumatoid arthritis has been deployed in the Pacific Northwest for clinical use. The neuroimmune modulation therapy continues to expand access across the United States.

Importance:3/10
Sentiment:
0.60
FDA-approvedNeuroimmune modulationRheumatoid ArthritisCommercial expansionMedical device
Related Companies

Read the original article

Published by PR Newswire Clinical Trials on September 16, 2026 12:00 PM

Read Original